Metropolitan Life Insurance CO Iveric Bio, Inc. Transaction History

Metropolitan Life Insurance CO

$2.27 Billion
Q1 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $16,037 - $21,097	-859 Reduced 10.32%	7,465 $181,000
Q4 2022 Jun 14, 2023	BUY	$17.24 - $23.95 $14,809 - $20,573	859 Added 11.51%	8,324 $178 Million
Q4 2022 Mar 30, 2023	BUY	$17.24 - $23.95 $13,878 - $19,279	805 Added 10.71%	8,324 $178,000
Q4 2022 Feb 15, 2023	BUY	$17.24 - $23.95 $13,878 - $19,279	805 Added 10.71%	8,324 $178,000
Q3 2022 Jun 14, 2023	BUY	$9.4 - $18.59 $507 - $1,003	54 Added 0.72%	7,519 $135 Million

Q2 2022 Jun 20, 2023	BUY	$9.12 - $18.9 $492 - $1,020	54 Added 0.72%	7,519 $72,000
Q1 2022 Jun 20, 2023	BUY	$12.15 - $16.83 $656 - $908	54 Added 0.72%	7,519 $126,000
Q1 2022 Mar 30, 2023	SELL	$12.15 - $16.83 $271,297 - $375,797	-22,329 Reduced 74.81%	7,519 $126,000
Q1 2022 May 12, 2022	SELL	$12.15 - $16.83 $271,297 - $375,797	-22,329 Reduced 74.81%	7,519 $127,000
Q4 2021 Jun 21, 2023	BUY	$13.83 - $18.78 $309,556 - $420,352	22,383 Added 299.84%	29,848 $499,000
Q4 2021 Mar 30, 2023	BUY	$13.83 - $18.78 $35,985 - $48,865	2,602 Added 9.55%	29,848 $499,000
Q4 2021 Feb 15, 2022	BUY	$13.83 - $18.78 $35,985 - $48,865	2,602 Added 9.55%	29,848 $499,000
Q3 2021 Jun 21, 2023	BUY	$7.07 - $17.5 $139,851 - $346,167	19,781 Added 264.98%	27,246 $442,000
Q3 2021 Mar 30, 2023	BUY	$7.07 - $17.5 $13,701 - $33,915	1,938 Added 7.66%	27,246 $442,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $13,701 - $33,915	1,938 Added 7.66%	27,246 $442,000
Q2 2021 Jun 21, 2023	BUY	$5.69 - $7.17 $101,526 - $127,934	17,843 Added 239.02%	25,308 $159,000
Q2 2021 Mar 30, 2023	BUY	$5.69 - $7.17 $72,905 - $91,869	12,813 Added 102.55%	25,308 $159,000
Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $143,934 - $181,372	25,296 Added 210800.0%	25,308 $160,000
Q1 2021 Jun 26, 2023	BUY	$5.08 - $6.89 $25,552 - $34,656	5,030 Added 67.38%	12,495 $77.2 Million
Q1 2021 Mar 30, 2023	SELL	$5.08 - $6.89 $50,860 - $68,982	-10,012 Reduced 44.48%	12,495 $77,000
Q1 2021 May 14, 2021	SELL	$5.08 - $6.89 $114,274 - $154,990	-22,495 Reduced 99.95%	12 $77,000
Q4 2020 Jun 22, 2023	BUY	$5.65 - $7.66 $84,987 - $115,221	15,042 Added 201.5%	22,507 $155,000
Q4 2020 Mar 30, 2023	SELL	$5.65 - $7.66 $15,464 - $20,965	-2,737 Reduced 10.84%	22,507 $155,000
Q4 2020 Feb 16, 2021	SELL	$5.65 - $7.66 $15,464 - $20,965	-2,737 Reduced 10.84%	22,507 $156,000
Q3 2020 Jun 26, 2023	BUY	$4.01 - $6.29 $71,293 - $111,829	17,779 Added 238.16%	25,244 $142,000
Q3 2020 Mar 30, 2023	BUY	$4.01 - $6.29 $38,363 - $60,176	9,567 Added 61.03%	25,244 $142,000
Q3 2020 Nov 13, 2020	BUY	$4.01 - $6.29 $38,363 - $60,176	9,567 Added 61.03%	25,244 $142,000
Q2 2020 Jun 26, 2023	BUY	$3.06 - $6.6 $25,128 - $54,199	8,212 Added 110.01%	15,677 $79,000
Q2 2020 Mar 30, 2023	BUY	$3.06 - $6.6 $22,500 - $48,529	7,353 Added 88.33%	15,677 $79,000
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $47,971 - $103,468	15,677 New	15,677 $80,000

Others Institutions Holding ISEE

# of Institutions

Shares Held

250K

Call Options Held

40K

Put Options Held

View Full List

About IVERIC bio, Inc.

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

More about ISEE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account